Medical Devices News and Research

RSS

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

EDAP TMS introduces Albatherm HIFU device for prostate cancer in Chinese healthcare market

EDAP TMS SA, the global leader in therapeutic ultrasound, announced today that it will expand into the rapidly growing Chinese healthcare market with its Albatherm HIFU device for the treatment of prostate cancer. Ablatherm HIFU will be distributed throughout China by Shaw Han Biomedical Co. Ltd.

26 Aug 2010

IIC-China to feature live teardown of latest portable blood pressure measurement device

Global Sources announces today that top international and local technology experts are scheduled to speak at the 15th International IC-China Conference & Exhibition Fall Edition. The event, which features mainland China's very first live product teardowns, is set to take place in two major electronics design and manufacturing hubs in Southern and Western China:

26 Aug 2010

AdvanSource receives patent for Antimicrobial Polyurethane Resins to eradicate MRSA

AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office in connection with its antimicrobial patent application filed in June 2007. U.S. Patent No. 7,772,296, which is entitled "Antimicrobial Polyurethane Resins and Products Made Therefrom," covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus ("MRSA") clinical infections associated with medical devices.

26 Aug 2010

NCPA releases unbiased, detailed analysis of health care reform costs and benefits

The first detailed and objective consumer's guide on the impact of the Patient Protection and Affordable Care Act has just been released by the National Center for Policy Analysis (NCPA), titled "What Does Health Care Reform Mean To You? A Detailed Analysis"

26 Aug 2010

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Cancer diagnostics company Biomoda, Inc. has received a notice of allowance for a Canadian patent application for a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes them to fluoresce under specific frequencies of light when viewed under a fluorescent microscope.

26 Aug 2010

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Researchers from North Carolina State University have developed extremely small microneedles that can be used to deliver medically-relevant nanoscale dyes called quantum dots into skin - an advance that opens the door to new techniques for diagnosing and treating a variety of medical conditions, including skin cancer.

26 Aug 2010

Baxa ranked 3,494 on Inc. 5000 list of US fastest-growing private businesses

Baxa Corporation today announced its rank of 3,494 on the Inc. 5000 list of the fastest-growing private businesses in the United States. This year marks the fourth consecutive year that Baxa, a leading provider of medical devices and systems that automate pharmacy operations, has been listed on the prestigious Inc. 5000 list.

26 Aug 2010

Device firms skid as health IT looks to bright future

As companies look forward to a bright future in some areas of health technology--namely, electronic medical records--other parts of the med-tech industry are watching sales slip.

26 Aug 2010

ORLocate system designed to prevent medical errors in surgical procedures receives FDA clearance

A new technology that tracks instruments and sponges during surgical procedures has earned clearance from the Food and Drug Administration.

25 Aug 2010

Pen-size plasma sterilization device

Prof. Jiunn-Der Liao of Department of Materials Science and Engineering at National Cheng Kung University (NCKU), Tainan, Taiwan, has led Post Doctorate Chih-Chiang Weng and a research team to develop a pen-size plasma sterilization device which can sterilize instruments and wounds by relying on the process of plasma sterilization.

25 Aug 2010

3Sbio, Isotechnika Pharma sign development and commercialization agreement for voclosporin inhibitor

Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, and 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.

25 Aug 2010

Health law continues to be embroiled in politics, though toned down

In a bid to rally support for the health overhaul among doctors, a White House official underscored both sticks and carrots the federal government is offering the health industry, Reuters reports: "Administration officials said the new law will provide doctors with information technology and incentives to improve the care they deliver, but only if they cooperate.

25 Aug 2010

CIMIT, Induct announce strategic alliance to implement Web-based innovation management system

The Center for Integration of Medicine and Innovative Technology and Induct Software, "The Open Innovation Company," today announced a long-term strategic alliance under which they will work together to implement a Web-based innovation management system based upon the successful CIMIT Model.

25 Aug 2010

Medco to expand comp effectiveness reach

Modern Healthcare: "Pharmacy-benefit manager Medco Health Solutions' recent announcement of plans to acquire United BioSource Corp. for $730 million has many wondering if this will be the first of many companies seeking to extend their reach in the growing comparative effectiveness market.

25 Aug 2010

DSM Biomedical signs new licensing agreements with global medical device manufacturers

DSM Biomedical, a global leader in biomedical materials science, and its Berkeley based operation, DSM PTG, today announced the company has entered into six multi-year licensing agreements with global medical device manufacturers in the Orthopedic, Cardiovascular, Vascular and Urology fields in this year alone.

25 Aug 2010

Cyberonics enters agreement with NeuroVista for epilepsy technology development program

Cyberonics, Inc. today announced that it has entered into additional agreements with NeuroVista Corporation in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy.

25 Aug 2010

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced that the Company has entered into a multi-year supply agreement with a leading multi-national medical device company. This supply agreement is the result of the Company's successful performance on a development agreement, which was entered into with this customer in June 2009.

25 Aug 2010

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Urologix, a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for its fourth quarter ended June 30, 2010 and for fiscal year 2010.

25 Aug 2010

BioJapan 2010 announces 'Renaissance of Bioindustry' as main theme

BioJapan Organizing Committee will hold the BioJapan 2010 - World Business Forum, scheduled September 29 - October 1 at Pacifico Yokohama, Japan. BioJapan 2010 will revolve around four main topics, 1) Health (Drugs, Medical Devices, and Cosmetics), 2) Environment (Biofuel, Biorefinery, and Biomass Plastics), 3) Food (Functional food), and 4) Clusters & Bio-ventures. At same time, BioJapan will offer various programs integrating exhibitions and seminars.

24 Aug 2010

Medical Devices News and Research

Aethlon Medical receives approval for Chronic HCV Infection treatment

EDAP TMS introduces Albatherm HIFU device for prostate cancer in Chinese healthcare market

IIC-China to feature live teardown of latest portable blood pressure measurement device

AdvanSource receives patent for Antimicrobial Polyurethane Resins to eradicate MRSA

NCPA releases unbiased, detailed analysis of health care reform costs and benefits

Biomoda's CyPath assay for lung cancer detection receives Canadian patent

Researchers develop microneedles to deliver quantum dots for skin cancer treatment

Baxa ranked 3,494 on Inc. 5000 list of US fastest-growing private businesses

Device firms skid as health IT looks to bright future

ORLocate system designed to prevent medical errors in surgical procedures receives FDA clearance

Pen-size plasma sterilization device

3Sbio, Isotechnika Pharma sign development and commercialization agreement for voclosporin inhibitor

Health law continues to be embroiled in politics, though toned down

CIMIT, Induct announce strategic alliance to implement Web-based innovation management system

Medco to expand comp effectiveness reach

DSM Biomedical signs new licensing agreements with global medical device manufacturers

Cyberonics enters agreement with NeuroVista for epilepsy technology development program

AdvanSource Biomaterials enters multi-year agreement to supply hydrophilic polymer resins

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

BioJapan 2010 announces 'Renaissance of Bioindustry' as main theme

Industry Focus - Medical Device eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News